# A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

> **NCT01199289** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 315 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AMG 827
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01199289
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-04
- **Primary completion:** 2011-12-21
- **Final completion:** 2011-12-21
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01199289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01199289, "A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01199289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*